sion can be used to ensure that solidarity does not remain vague or underdetermined in discussions of TB policy.
The purpose of this article, then, is twofold: first, to describe the ethical challenges associated with D&I of new TB technologies by drawing on TB stakeholder perspectives and using solidarity as an explanatory concept, and second, to begin to articulate the ethical implications of solidarity for TB D&I. The overall conclusion is that properly developing and implementing new technologies for TB necessitates addressing the sociopolitical conditions that facilitate transmission and hinder eradication efforts. Justifying such interventions and understanding how they ought to occur requires, in part, understanding the role that solidarity plays in such arguments. We draw on two dominant bioethical accounts of solidarity, which articulate its meaning and moral significance in the context of health, to help conceptualize the ethical challenges facing TB D&I as identified by respondents.
We begin with a background on TB technology D&I followed by an outline of the theoretical accounts of solidarity that inform our analysis and interpretation of the stakeholder interviews. Then, we present the findings of our empirical investigation with an integrated conceptual discussion to address our dual objectives of developing a descriptive account and providing normative guidance with respect to the ethical challenges facing TB D&I. 9 We note at the outset that participants never explicitly used the term 'solidarity'; instead, we interpreted their comments as being directly about solidarity, or the lack thereof, based on our understanding of ethical theory about solidarity, which we use for its explanatory power in our analysis. Similarly, despite there being two prominent articulations of solidarity in the recent bioethics literature (and despite one of the present authors, [Angus Dawson], being a co-author of one account), we remain agnostic, here, as to their relative merits; rather, we use them to interpret participant responses, which spoke to both accounts. Finally, the main aim of our paper is descriptive and any normative ethics arguments presented will be nascent in their articulations; a fully developed normative account of how solidarity may better inform TB D&I is beyond the scope of this paper.
| BACKG ROU N D
TB is an aerially transmitted bacterial infection that caused an estimated 10.4 million incident active cases and 1.7 million deaths in
2016.
10 Despite a longstanding understanding of its etiology, preventive measures, and available treatments, efforts to eradicate
World Health Organization (WHO). (2017). Moscow Declaration to End TB. Available from:
http://www.who.int/tb/features_archive/Moscow_Declaration_to_End_TB_final_ ENGLISH.pdf [Accessed Dec 20, 2017] .
World Health Organization (WHO). (2018). UN General Assembly High-Level Meeting on
Ending TB. 6 WHO (2015) , op. cit. note 5, p. 4 (emphasis added).
7 Benatar S. R., Daar, A., & Singer, P. A. (2003) . Global health ethics: The rationale for mu- 8 Dawson, A., & Jennings, B. (2012) . The place of solidarity in public health ethics. Public Health Reviews, 34(1), 65-79; Prainsack, B., & Buyx, A. (2017 Progressing along the arc of solidarity demands greater moral discernment and commitment, requiring a shift from 'seeing health as personal achievement or a matter of the biological lottery to seeing health (and illness) as something mutual, something that creates responsibilities of care and concern incumbent on us all'.
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Although the instrumental and intrinsic accounts of solidarity have both points of convergence and divergence, rather than endorsing one account here, we employ both to interpret the full range of interviewee responses and consider the associated normative implications.
| ME THODS

| Sampling
We interviewed a purposive sample of 23 participants from three major stakeholder groups in TB technological policy: 37 policy mak- which we modified throughout the study as we sought to deepen our understanding of topics that were not raised in earlier interviews.
| Data collection
| Analysis
We conducted a qualitative thematic analysis. 41 We developed codes and themes from the transcripts, but were sensitized to and used bioethical concepts to inform our interpretation of participant responses during coding and thematic aggregation. One team member coded the transcripts in NVivo 11 based on a codebook that was developed jointly by the research team and to which codes were added and discussed by the team. The PI and a second team member each prepared analytic memoranda summarizing key themes and quotations for every interview. We discussed the emerging analysis through bi-weekly meetings.
Once the interviews were discussed individually and then collectively, we developed preliminary themes and reviewed them in relation to the data, codes, and each other, and then organized them into higher-level, analytic themes. 42 We shared a document summarizing the preliminary analytic themes with the respondents, 10 of whom responded with comments, which we used as additional data. Finally, as we identified solidarity as a central moral consideration in our interpretation of participant responses in the initial thematic analysis, we looked to the bioethics literature on solidarity to inform a subsequent conceptual and normative analysis of the findings 43 , and in particular, to understand the normative nature and implications of solidarity in the context of TB.
| FIND ING S AND D ISCUSS I ON
We identified three key ethical challenges and two responses that participants raised with respect to the D&I of new TB technologies. The fundamental ethical challenge facing D&I is the failure in solidarity in TB. Solidarity features as the central concept in our analysis as it is both morally significant in its own right and underpins the remaining, interconnected ethical issues raised by participants, including power imbalances and balancing risks and benefits. Participants identified advocacy and participatory D&I, which can be understood as ways of engendering solidarity, as responses to these challenges and ways of improving TB research, prevention, and care.
| A failure in solidarity: The fundamental ethical challenge
The fundamental ethical challenge facing the D&I of new TB technologies can be understood as a failure in solidarity -a failure to identify and stand with persons and communities affected by TB and to respond to the social and political embeddedness of TB. Although participants did not explicitly use the term 'solidarity', they indicated that a lack of political will, manifest by persistent failures to address background social and political conditions, as well as insufficient attention to the needs of persons with TB and affected communities, lay at the crux of the challenges facing TB D&I. As an explanatory category, the failure in solidarity best captures the common thread across such views.
There are a lot of things that can improve, but why is it possible that a country like Cuba has managed to control TB, and it's on the path of elimination? A poor coun- all these arguments about lack of resources … these are feeble excuses to hide the lack of political will. We want to make it happen, it will happen. (Interview 1)
Significantly, respondents noted that because TB largely affects persons who are impoverished, disenfranchised, and stigmatizedthe 'other' -there is a fundamental lack of awareness about, and interest in, TB, in both low-and high-burden countries. Although participants did not explicitly invoke the notion of the 'other', the relationships they described mirror the process of othering inherent in us-and-them distinctions that undermine solidarity.
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TB really seems to be -well, how do I say? Invisible to Another respondent, when asked to clarify why high-income, lowburden countries have a responsibility to address TB globally, firmly dismissed self-interest as a motiving factor:
Compassion for your fellow human being … There's nothing else that drives it. Because I think secondary gain for us is not the reason to pursue it … We need to care because we need to care about everyone glob-
ally, that's it. (Interview 5)
Thus, as in the ethics literature, participants justified obligations of solidarity in TB both on instrumental and intrinsic grounds.
| Solidarity as an 'enmeshed' concept
Solidarity captures a variety of ethical concerns raised by respondents in our analysis: the social embeddedness of TB, the 'otherness' of persons and communities affected by TB, the lack of political will to address TB, and the collective responsibility of the TB community (i.e., individuals and organizations working within the field of TB, broadly construed), HICs, and even LMICs, to advocate for and aid persons and communities affected by TB to eliminate what ought to be a curable disease. However, solidarity also serves as an organizing concept that informs an understanding of, and is instrumental to, successfully addressing other ethical challenges that participants raised. The notion that solidarity informs an understanding of other ethical issues raised by respondents echoes how Jennings and
Dawson describe solidarity as an '"enmeshed" or "implicated" concept, a value that supports and structures the way we in fact do and ought to see other kinds of moral considerations'.
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The ways in which participants described skewed relations be- Consequently, we explore the implications of the ensuing ethical issues raised by participants in light of solidarity.
| Power imbalances
Respondents described power imbalances within and beyond the TB community as ethically concerning, since powerful actors -who are seldom affected by TB -dictate whether and how D&I ought to be pursued, irrespective of local needs. Participants described how power differentials exist at many levels: globally, for example, between high-and low-income countries, which correspond to lowand high-burden countries, respectively; locally, for example, be- Moreover, the reliance on philanthropic and foreign funding stems in part from power imbalances in TB technology markets where forprofit companies are reluctant to invest in TB as they do not expect a good return on investment from a patient population that is largely poor.
Charity, however, is also predicated on a power imbalance; it is a top-down and asymmetric interaction between the donor and recip- 
| Balancing risks and benefits
| Balancing risks and benefits for individual patients
Granting persons with M/XDR-TB access to drugs that have yet to undergo phase III clinical trials on compassionate grounds is ethically contentious because of the heightened uncertainty, safety concerns, and power imbalances associated with TB and last-resort treatments. 53 Nonetheless, respondents consistently asserted that persons with M/XDR-TB should be granted access to new drugs.
Respondents cited that the potential, albeit still uncertain, benefits of bedaquiline and delamanid outweighed the known, serious risks associated with existing therapies for M/XDR-TB.
Initially the finding about the deaths [in the bedaquiline trials] that were unexplained was of con- Furthermore, it requires attending to the broader sociopolitical contexts that shape risks and benefits, which we turn to next.
| Public health: Whose risk and whose benefit?
Participants were less certain as to how potential benefits associated with accessing experimental or new drugs for individual patients ought to be balanced with the potential risks to populations.
In particular, some respondents were concerned that the premature administration of drugs in contexts where appropriate use could not be ensured would result in drug resistance, which could jeopardize The biggest issue is the balance of wide-scale access against the potential of undermining the true value so as to 'begin with the end in mind' (Interview 16) and develop technologies that are responsive to the realities and most urgent needs of high-burden contexts. Finally, our analysis suggests that the challenges facing TB elimination are characterized by a key practical and ethical concern: a failure within and beyond the TB community to identify, stand, and act in concert with persons and communities affected by TB -a failure in solidarity. Fundamentally, addressing TB requires policies that both support technological advances and attend to the sociopolitical contexts that enable TB to thrive and limit technological D&I. Necessary sociopolitical changes require solidarity across and beyond the TB community.
This includes raising awareness about TB through advocacy and ac- is necessary to fully understand the challenges and opportunities for enacting solidarity in TB. Moreover, further conceptual work is required to identify a preferred normative account of solidarity for justifying and guiding TB policy. Notwithstanding these limitations, our findings caution that the failure to enact solidarity threatens the D&I of new TB technologies and, ultimately, global TB eradication efforts as called for in the End TB Strategy and the Sustainable Development Goals.
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